London · Delayed Price · Currency is GBP · Price in GBX Oxford BioDynamics Company Description
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom.
The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.
Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling.
The company was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.
| Country | United Kingdom |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 51 |
| CEO | Jon Anthony Burrows |
Contact Details
Address: 3140 Rowan Place Oxford, OX4 2WB United Kingdom | |
| Phone | 44 1865 518 910 |
| Website | oxfordbiodynamics.com |
Stock Details
| Ticker Symbol | OBD |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | October - September |
| Reporting Currency | GBP |
| ISIN Number | GB00BD5H8572 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Jon Anthony Burrows | Chief Executive Officer |
| Paul Stockdale | Chief Financial Officer |
| Thomas Guiel | Chief Operating Officer |